MKI67 and breast carcinoma: Although there is a collective recognition among the international guideline recommendations that Ki-67 is a prognostic biomarker in breast cancer, the international guideline recommendations for the use of Ki-67 in the prognostic and predictive evaluation of breast cancer remains mixed [14].